-
Britain's Hunt wins 200m for European sprint double
-
US stocks gain after benign inflation data, oil prices retreat
-
Draper dumped as Norrie saves face for Britain in Cincinnati
-
LeBron's Sixers in spotlight as full 2026-27 NBA schedule revealed
-
England opener Gay out for duck in Pakistan warm-up
-
Kennedy Center board votes to restore Trump name: reports
-
Europe swelters under fresh wave of extreme heat
-
Barcelona agree to sell Torres to PSG: media
-
French Olympic gold medallist Florent Manaudou announces retirement
-
Romania shuts nuclear plant as Danube drops
-
Tourists rescued by boat as forest fire threatens Greek beaches
-
Millions of Europeans struggle with another wave of extreme heat
-
Indicted Raul Castro reappears after months out of public view
-
Israel reopens once-closed West Bank settlement
-
Italian teen Curtis breaks women's 50m backstroke world record for second time
-
Taylor to captain New Zealand for first time against Bulls
-
Taulagi steps out of 'comfort zone' with code switch to French Top 14 new boys
-
Carrick urges Man Utd to push for more signings to boost title bid
-
Leicester's Thai owners put troubled club up for sale: reports
-
'This was my World Cup' says Somali ref after UEFA Super Cup
-
Stocks steady as US inflation worries ease, oil slips
-
Survivors tell of horror of Zimbabwe ferry sinking as death toll hits 46
-
Porsche to end production of flagship electric car: report
-
Juventus forward Vlahovic signs three-year Besiktas deal
-
Twitch sparks gamers' wrath with Amazon AI sharing deal
-
Tielemans apologises for offending Villa fans with Man Utd boast
-
Blaze forces families to abandon Turkish tour boat
-
Stocks gain as US inflation worries ease, oil slips
-
'If you can, move!' say Rome's viral dancing seniors
-
Heavy rain soaks eastern Japan, prompting highest-level warning
-
Zambia voters weigh Hichilema's economic record
-
Celtic boss O'Neill 'much better' after hospital procedure
-
SBCFX to Showcase Trading Innovation, Regional Growth Strategy, and Future Vision at iFX EXPO Asia 2026
-
MEXC July TradFi Trading Shifts Toward AI Storage as SNDK Futures Volume Surges More Than 15x Times
-
Hodgkinson sets up Werro showdown after Euro 800m drama
-
Maghreb sees demographic shift with fertility at historic low
-
'How many will die?': the mysterious ailment killing Kenyan elephants
-
European stocks gain as oil prices ease
-
Arteta coy over Lewis-Skelly's Arsenal future after 'emotional' celebration
-
Infantino future should be decided by election says African football chief
-
Romania shuts down nuclear plant as Danube drops
-
Man City star Doku signs five-year contract extension
-
German steel giant Thyssenkrupp weighs options as Rhine drops
-
Fabien Barthez joins Zidane's new France coaching setup
-
US ambassador denounces settler siege as Israel dispatches troops
-
Taiwan chokes mobile internet speeds in drill for Chinese attack
-
Hasan takes 6-55 as Bangladesh claim opening day of Australia Test
-
From Chinese AI to Global ETFs: STARTRADER Launches 45 New 24/7 Stock and ETF CFDs
-
Taiwan says AI agents used in cyberattacks targeting island
-
Tech stocks enjoy rebound after US inflation on mixed day for markets
US researchers seek to legitimize AI mental health care
Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.
Their application, Therabot, addresses the critical shortage of mental health professionals.
According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.
"We need something different to meet this large need," Jacobson told AFP.
The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.
A new trial is planned to compare Therabot's results with conventional therapies.
The medical establishment appears receptive to such innovation.
Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."
Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.
Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.
Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.
The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.
They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.
- Care or cash? -
With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.
According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.
Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.
Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.
"There are still a lot of questions," King noted.
To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.
While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.
Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.
The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."
- Therapist always in -
Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."
Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.
"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.
AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.
"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.
One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.
"I feel like it's working for me," he said.
"I would recommend it to people who suffer from anxiety and are in distress."
T.Ibrahim--SF-PST